Proportions of CD4+, CD8+ and B cell subsets are not affected by exposure to HIV or to Cotrimoxazole prophylaxis in Malawian HIV-uninfected but exposed children

BMC Immunology
Herbert LongweWilson L Mandala

Abstract

As a result of successful PMTCT programs, children born from HIV-infected mothers are now effectively protected from contracting the infection. However, it is not well known whether in utero exposure to the virus and the subsequent exposure to Cotrimoxazole (CTX) prophylaxis affect the cell mediated immune system of the children. This observational prospective study was aimed at determining how CD4(+) T, CD8(+) T and B cell subsets varied in HIV-exposed but uninfected (HEU) children at different ages. We recruited HEU and HIV-unexposed and uninfected (HUU) children from 6 months of age and followed them up until they were 18 months old. HEU children received daily CTX prophylaxis beginning at 6 weeks of age until when 12 months of age. Venous blood samples were collected 6 monthly and analysed for different subsets of CD8(+) T, B cells and totalCD4(+) T cells. At 6 months of age, HEU children had a lower percentage of total CD4(+) T cells compared to HUU children and a lower proportion of naïve CD8(+) T cells but higher percentage of effector memory CD8(+) T cells compared to HUU children. HEU and HUU children had similar proportions of all B cell subsets at all ages. The study showed that the subtle variations in CD4(+) and CD...Continue Reading

References

Mar 23, 2004·Annual Review of Immunology·Federica SallustoAntonio Lanzavecchia
Jan 26, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·UNKNOWN European Collaborative Study
Apr 20, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A Sarah WalkerUNKNOWN CHAP Team
May 29, 2007·The Pediatric Infectious Disease Journal·Edmore MarindaUNKNOWN ZVITAMBO Study Group
Nov 14, 2007·Immunology and Cell Biology·Marie LewisStephen Cose
Sep 18, 2008·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·E OnoM I de Moraes-Pinto
Mar 26, 2009·Nature Reviews. Immunology·Susan Moir, Anthony S Fauci
Jul 14, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Greta E WeissSusan K Pierce
Dec 1, 2009·The Journal of Allergy and Clinical Immunology·Wilson L MandalaCalman A MacLennan
May 5, 2012·Journal of Tropical Pediatrics·Amy SlogroveTobias Kollmann
Dec 12, 2013·Clinical and Experimental Immunology·L AfranS L Rowland-Jones
Jan 21, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Cinta MoraledaDenise Naniche
Mar 25, 2014·Trends in Immunology·Jan C RohrTon N Schumacher
Apr 20, 2014·Frontiers in Immunology·Nelly RobillardMarie C Béné

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

STATA
GraphPad Prism

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.